These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 24783226)

  • 21. GADA and islet cell antibodies in Romanian children and adolescents with diabetes mellitus.
    Serban V; Enache A; Vlad A; Sima A; Roşu M; Roşca A; Drăghici C
    Rom J Intern Med; 2004; 42(2):325-32. PubMed ID: 15529623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of serum and EDTA plasma in the measurement of glutamic acid decarboxylase autoantibodies (GADA) and autoantibodies to islet antigen-2 (IA-2A) using the RSR radioimmunoassay (RIA) and enzyme linked immunosorbent assay (ELISA) kits.
    Rahmati K; Lernmark A; Becker C; Foltyn-Zadura A; Larsson K; Ivarsson SA; Törn C
    Clin Lab; 2008; 54(7-8):227-35. PubMed ID: 18942490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pancreatic autoantibodies in Italian patients with newly diagnosed type 1 diabetes mellitus over the age of 20 years.
    Betterle C; Lazzarotto F; Fusari A; Zanchetta R; Benedini S; Pedini B; Moscon A; Presotto F
    Acta Diabetol; 2006 Nov; 43(3):79-83. PubMed ID: 17143785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: a comparison with those present in type 1 diabetes.
    Tremble J; Morgenthaler NG; Vlug A; Powers AC; Christie MR; Scherbaum WA; Banga JP
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2664-70. PubMed ID: 9253351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases.
    Lindholm E; Hallengren B; Agardh CD
    Diabetes Metab Res Rev; 2004; 20(2):158-64. PubMed ID: 15037992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [IA-2 and anti-GAD antibodies in patients with newly diagnosed type 1 diabetes and their first degree relatives].
    Kretowski A; Kowalska I; Peczyńska J; Urban M; Kinalska I
    Przegl Lek; 2000; 57(3):143-6. PubMed ID: 10909282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoantibodies against glutamic acid decarboxylase 65 in Japanese patients with insulin-dependent diabetes mellitus (IDDM).
    Yano M; Moriuchi R; Kawasaki E; Watanabe M; Saito K; Takino H; Akazawa S; Miyamoto T; Nagataki S
    J Autoimmun; 1995 Feb; 8(1):83-96. PubMed ID: 7734039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GADA titer-related risk for organ-specific autoimmunity in LADA subjects subdivided according to gender (NIRAD study 6).
    Zampetti S; Capizzi M; Spoletini M; Campagna G; Leto G; Cipolloni L; Tiberti C; Bosi E; Falorni A; Buzzetti R;
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3759-65. PubMed ID: 22865904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoantibodies to GAD65 and IA-2 in canine diabetes mellitus.
    Davison LJ; Weenink SM; Christie MR; Herrtage ME; Catchpole B
    Vet Immunol Immunopathol; 2008 Nov; 126(1-2):83-90. PubMed ID: 18706702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GAD autoantibody affinity and epitope specificity identify distinct immunization profiles in children at risk for type 1 diabetes.
    Mayr A; Schlosser M; Grober N; Kenk H; Ziegler AG; Bonifacio E; Achenbach P
    Diabetes; 2007 Jun; 56(6):1527-33. PubMed ID: 17325256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of immunoassays for the detection of anti-GAD65 autoantibodies in patients with diabetes mellitus.
    Pfützner A; Harzer O; Kunt T; Forst T; Abdollahnia N; Löbig M; Krauss H; Engelbach M; Kann P; Beyer J
    Clin Lab; 2000; 46(5-6):275-9. PubMed ID: 10853236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnostic efficacy of glutamic acid decarboxylase antibody and islet cell antibody in type I diabetes mellitus].
    Ouyang L; Wang J; Zhu X
    Zhonghua Nei Ke Za Zhi; 2000 Oct; 39(10):674-6. PubMed ID: 11374174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunologic and genetic markers in insulin-dependent diabetes mellitus (type 1) in an Argentine population.
    Krochik AG; Mazza CS; Valdez SN; Stumpo RR; Papouchado ML; Iacono RF; Cardoso Landaburu AC; Sica MP; Ozuna B; Poskus E
    Medicina (B Aires); 2001; 61(3):279-83. PubMed ID: 11474874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A sensitive non-isotopic assay for GAD65 autoantibodies.
    Brooking H; Ananieva-Jordanova R; Arnold C; Amoroso M; Powell M; Betterle C; Zanchetta R; Furmaniak J; Smith BR
    Clin Chim Acta; 2003 May; 331(1-2):55-9. PubMed ID: 12691864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-titer GAD65 autoantibodies detected in adult diabetes patients using a high efficiency expression vector and cold GAD65 displacement.
    Hansson I; Lynch KF; Hallmans G; Lernmark Å; Rolandsson O
    Autoimmunity; 2011 Mar; 44(2):129-36. PubMed ID: 20670115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency of pancreatic beta-cell autoimmunity markers in patients with autoimmune thyroid disease.
    Primo ME; Niepomniszcze H; Poskus E; Sala MS; Guaita SS; Sica MP; Villalba A; Cardoso A; Bruno OD
    Medicina (B Aires); 2008; 68(1):37-42. PubMed ID: 18416318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoantibodies to GAD and IA-2 in Saudi Arabian diabetic patients.
    Damanhouri LH; Dromey JA; Christie MR; Nasrat HA; Ardawi MS; Robins RA; Todd I
    Diabet Med; 2005 Apr; 22(4):448-52. PubMed ID: 15787671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time-resolved fluorometric assay for detection of autoantibodies to glutamic acid decarboxylase (GAD65).
    Ankelo M; Westerlund-Karlsson A; Ilonen J; Knip M; Savola K; Kankaanpää P; Meriö L; Siitari H; Hinkkanen A
    Clin Chem; 2003 Jun; 49(6 Pt 1):908-15. PubMed ID: 12765987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antibodies to glutamic acid decarboxylase (GADA) as markers of risk for development of insulin-dependent diabetes mellitus].
    Kretowski A; Szelachowska M; Kowalska I; Peczyńska J; Urban M; Kinalska I
    Przegl Lek; 1998; 55(6):315-9. PubMed ID: 9857706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency of glutamic acid decarboxylase autoantibodies in Mexican diabetic children.
    Mendoza-Morfín F; Curiel-Pérez MO; Cárdenas-Tirado H; Montero-González P; Gutiérrez-Avila C; Bravo-Ríos LE; Cárdenas-Cornejo I; Normandía-Almeida MA
    Rev Invest Clin; 2000; 52(4):427-31. PubMed ID: 11061105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.